Comparing empagliflozin and metformin for muscle health in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests two diabetes medications, empagliflozin and metformin, to see how they affect muscle energy use and blood flow in men with recently diagnosed type 2 diabetes. Participants will be followed at a diabetes clinic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and between 18 and 75 years old.
- Your type 2 diabetes was diagnosed within the last 2 years.
- You have a body mass index (BMI) between 25 and 35.
- You have never taken diabetes medication except for sulfonylureas (a type of pill).
- You do not have conditions like spinal cord injury, multiple sclerosis, cystic fibrosis, or joint immobility that affect muscle function.
- You do not have heart failure (NYHA class II or higher) or chronic kidney disease (stage 3 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of two diabetes medicines (henagliflozin proline and metformin XR) can improve body fat and muscle in older adults with type 2 diabetes. Participation may help you understand how your body responds to these medicines.
This trial tests a medication called empagliflozin (a type 2 diabetes pill) to see how well it works in people with type 2 diabetes who have not taken any diabetes drugs for at least 8 weeks. If you qualify, you may receive the study drug and help researchers learn more about managing blood sugar.
This study compares two diabetes medications, dapagliflozin and empagliflozin, to see which is more effective, safe, and affordable for people with type 2 diabetes and a high body weight. Both medications help lower blood sugar and may also help with weight loss.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This trial tests a new combination pill (henagliflozin and metformin) compared to metformin alone in people recently diagnosed with type 2 diabetes. The goal is to see which treatment works better and is safer.
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
Hear when a new Diabetes Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.